Dynavax Technologies Corp at Cowen Healthcare Conference (Virtual) Transcript
Good afternoon, and welcome once again to Cowen and Company's, hopefully last, Virtual Healthcare Conference. I'm Philip Nadeau, one of Cowen's biotech analysts, and it's my pleasure to moderate a fireside chat with Dynavax Technologies. We have with us Ryan Spencer, CEO; Michael Ostrach, who is in day 1 of his role as CFO emeritus, is also in the background to answer any questions, should they arise. Ryan, thanks for joining us today.
Questions & Answers
First, just I wanted to start off with kind of a broad question. Could you give a brief state of the company overview? What are Dynavax's biggest strengths today, its biggest challenges? And what do you think needs to happen to it to continue to create shareholder value?
Well, first, Phil, thanks for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
